Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients

International Journal of Cancer

Volumn 119, Issue 9, 2006, Pages 2221-2224

  Bairati, Isabelle ^a   Meyer, François ^a   Jobin, Edith ^a   Gélinas, Michel ^b   Fortin, André ^c   Nabid, Abdenour ^d   Brochet, François ^e   Têtu, Bernard ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^e Centre Hospitalier de la Sagamie   (Canada)

Author keywords

tocopherol; carotene; Antioxidant vitamins; Cancer; Mortality; Randomized trial

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH CERTIFICATE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANTIOXIDANTS; BETA CAROTENE; DIETARY SUPPLEMENTS; HEAD AND NECK NEOPLASMS; HUMANS; PLACEBOS; SURVIVAL ANALYSIS; VITAMINS;

EID: 33748855788     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22042     Document Type: Article

References (23)

1. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003;361:2017-23.
2. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004;364:1219-28.
3. Miller ER, Pastor-Bariuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
4. Bairati I, Meyer F, Gelinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Tetu B, Harel F, Masse B, Vigneault E, Vass S, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005;97:481-8.
5. Bairati I, Meyer F, Gelinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Tetu B, Harel F, Abdous B, Vigneault E, Vass S, et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 2005;23:5805-13.
6. Collett D. Modeliing survival data in medical research. Boca Raton: CRC Press, 2003.
7. The α-tocopherol, β-carotene cancer prevention group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
8. Omenn GS. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Jr, Valanis B, Williams JH, Jr, Barnhart S, Cherniack MG, et al. Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1050-5.
9. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. β-Carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999;91:2102-6.
10. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
11. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of Selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-22.
12. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto miocardio. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevention trial. Lancet 1999;354:447-55.
13. The HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer. J Am Med Assoc 2005;293:1338-47.
14. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Vitamin E in the primary prevention of cardiovascular disease and cancer. The Women's Health Study: a randomized controlled trial. J Am Med Assoc 2005;294:56-65.
15. Mitchinson MJ, Stephens NG, Parsons A, Bligh E, Schofield PM, Brown MJ. Mortality in the CHAOS trial. Lancet 1999;353:381-2.
16. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 2001;357:89-95.
17. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomized placebo-controlled trial. Lancet 2000;356:1213-18.
18. Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, Shoulson I, Tanner CM, Fahn S. High-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med 2005;143:152-3.
19. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988;48:612-9.
20. Roberts HJ. Perspective on vitamin E therapy. J Am Med Assoc 1981;246:129-31.
21. Huang HY, Appel LJ. Supplementation of diets with α-tocopherol reduces serum concentrations of γ- and δ-tocopherol in humans. J Nutr 2003;133:3137-40.
22. Ford ES, Ajani UA, Mokdad AH. The prevalence of high intake of vitamin E from the use of supplements among U.S. adults. Ann Intern Med 2005;143:116-20.
23. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137:889-903.